February 14, 2025 · Form 4 insider transaction
Espinoza Octavio bought 7,390 shares of Ligand Pharmaceuticals Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Represents shares of common stock issued upon the vesting and certification of performance stock units (PSUs).